Target intelligence / Profile preview

RNA, U2 small nuclear 8, pseudogene (RNU2-8P)

Target
RNU2-8P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

**RNA, U2 small nuclear 8, pseudogene (RNU2-8P)** is a human pseudogene that resembles genes encoding the U2 small nuclear RNA, a component of the spliceosome complex responsible for pre-mRNA splicing[1][4]. Unlike its functional counterparts, RNU2-8P is classified as a pseudogene, meaning it does not produce a functional RNA product and has no known biological function or disease association. Pseudogenes such as RNU2-8P typically arise from duplication or retrotransposition events and often contain sequence similarities to their functional parental genes but lack regulatory elements or contain disruptive mutations[4]. There is no evidence to support this as a therapeutic target, a biomarker, or a disease-causing locus. **Notes on correctness:** There is nothing technically misspelled in the name RNU2-8P, but the entity is a **pseudogene, not a protein, receptor, or functional RNA**, and it is not considered a drug target or a receptor. It should be annotated as a non-functional locus and not be included among actionable molecular targets such as enzymes or receptors[1][4].

Other names
RNU2-8PRNA, U2 small nuclear RNA 8, pseudogene
02

Biological functions

Other (no direct biological function; related RNAs are involved in pre-mRNA splicing, but pseudogenes are typically non-functional)
03

Disease associations

Other (none known)

Beyond the preview

Go deeper on RNA, U2 small nuclear 8, pseudogene (RNU2-8P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 8, pseudogene (RNU2-8P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call